Thomas Flaten
Stock Analyst at Lake Street
(0.6)
# 2454
Out of 5,340 analysts
45
Total ratings
37.50%
Success rate
3.13%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BDSX Biodesix | Maintains: Buy | 3 2 | 0.32 | 525% | 1 | May 14, 2025 | |
CSTL Castle Biosciences | Maintains: Buy | 40 35 | 16.73 | 109.21% | 6 | May 6, 2025 | |
OCX OncoCyte | Initiates Coverage On: Buy | 5 | 2.85 | 75.44% | 5 | Mar 28, 2025 | |
OPTN OptiNose | Downgrades: Hold | 17 9 | 9.73 | -7.5% | 5 | Mar 20, 2025 | |
CKPT Checkpoint Therapeut... | Downgrades: Hold | 7 5 | 4.16 | -1.44% | 5 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 8 | 2.35 | 240.43% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 6 | 1.72 | 248.84% | 2 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 9 | 4.97 | 81.09% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 9 | 6.92 | 30.06% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 1 | n/a | n/a | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | 0.68 | 341.18% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 11 | 3.08 | 257.14% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | n/a | n/a | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 25 | 23.55 | 6.16% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14400 1440 | 2.34 | 61438.46% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 8 | 4.21 | 90.02% | 1 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | May 13, 2022 |